En

News

EFMC Grants 2023 - Applications are open

EFMC is funding grants for EFMC organised events with the aim to support the participation of young academic scientists.

Upon application, a limited number of grants will be covered by EFMC, corresponding to:

  • The full registration fees for EFMC-ISMC, EFMC-ASMC, EFMC-ISCB and ACSMEDI-EFMC Medicinal Chemistry Frontiers
  • Up to 50% of the registration fees for the EFMC Short Courses

The following Grant applications for 2023 events are open

Once registered in the grant system, you will receive a confirmation email with your data to access your secured page, and upload the following:

  • Cover letter
  • Support letter by the supervisor
  • CV
  • Publications' List
  • Abstract of the Oral Communication/Poster Presentation (not required for the EFMC Short Course)

Please be informed that following EFMC regulations, only the members of an EFMC National Adhering Organisation will be allowed to apply for the EFMC grants.

EFMC announces the creation of the EFMC-WuXi AppTec Award for Excellence in Chemical Biology

The "EFMC-WuXi AppTec Award for Excellence in Chemical Biology" will recognise outstanding research in the field of chemical biology as defined by EFMC in The Chemical Biology-Medicinal Chemistry Continuum: EFMC’s Vision, ChemBioChem 2021, 22, 2823– 2825. 

The Award is given biennially and consists of a diploma, € 7.500 and an invitation to present a lecture on the occasion of the European Federation for Medicinal chemistry and Chemical Biology International Symposium on Chemical Biology (EFMC-ISCB).

The EFMC-ISCB 2023 will be held in Basel, Switzerland on November 16-18, 2023.

Deadline for submission: January 31, 2023 | Awardee will be announced in the course of May 2023!

This Award has been established with the support of WuXi AppTec.

EFMC Prizes 2023 - Call for Nominations

To acknowledge and recognise outstanding young medicinal chemists (≤ 12 years after PhD) working in European industry and academia.

The two Prizes consists of a diploma€ 1.000 and an invitation for a short presentation at an EFMC symposium.

Deadline: January 31, 2023

For the 2023 edition, the prize-winners will be invited to give an oral communications at the IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 2023), scheduled to take place in Zagreb, Croatia on September 3-7, 2023. Two additional nominees will also be identified and acknowladged as most meritorious runners-up. 

In Memoriam - Prof. Bernard Testa (1941-2022)

It was with great sadness that we learnt of the death of Prof. Bernard Testa, recipient of the 2002 Nauta Award for Pharmacochemistry and speaker at the first EFMC Short Course in Medicinal Chemistry.

He was highly considered by the community for his numerous and excellent contributions to the advancement of pharmaceutical sciences and medicinal chemistry, both as teacher and as researcher. His achievements in understanding the role of physiochemical properties in drug activity, more precisely in the disposition of medicines ought to be particularly recognised.

EFMC would like to remind his efforts, joint with Henk Timmerman and Han van de Waterbeemd, to launch the successful series of EFMC Short Course in Medicinal Chemistry in 2009 with a very successful course on “Improving Compound Quality: Physical Chemistry and DMPK Properties in Drug Discovery. Principles, Assays and Predictions”.

EFMC regrets the loss of this contributor to its history, and presents its condolences to his family.

Rui Moreira
EFMC President

EFMC Awards & Honorary Fellows 2022 - Ceremonies at EFMC-ISMC

Hosted at the occasion of 27th edition of the EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC) which took place on September 4-8, 2022 in Nice, France, the EFMC Award & Honorary Fellow ceremonies were the occasion to thank the individuals who have provided outstanding support to the EFMC or contributed to strengthening the position of medicinal chemistry, chemical biology, or related fields in Europe.

Prof. Herbert Waldmann (Max Planck Institute of Molecular Physiology, Germany) received the Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology for his pioneering contribution to medicinal chemistry and chemical biology, and for the broad range of breakthrough concepts that laid the foundation of chemical biology as a discipline. Herbert Waldmann’s research is deeply interdisciplinary and further includes influential articles covering cell-based screening, activity-based protein profiling and chemical proteomics, genetics, and biophysics methodologies. He has helped foster Europe’s scientific community through many partnerships across academia and industry and through his numerous scientific offspring.

Award Waldmann

Prof. Henk Timmerman, Dr Andele Nauta, Prof. Herbart Waldmann, Prof. Rui Moreira
Credits: Fabien Venturi

Prof. Mike Waring (Newcastle University, United Kingdom) received the UCB-Ehrlich Award for Excellence in Medicinal Chemistry for his conceptual work on the role of lipophilicity and for contributions to advancing the field of covalent inhibitors in medicinal chemistry. Mike Waring has been involved in drug discovery and development projects that have resulted in several drug candidates reaching clinical trials, including the EGFR inhibitor osimertinib for the treatment of non-small cell lung cancer. Overall, he has made impactful contributions to small molecule drug discovery using novel hit generation approaches such as DNA encoded libraries and fragment-based lead generation.

Award Waring

Dr Adrian Hall, Prof. Mike Waring, Prof. Rui Moreira
Credits: Fabien Venturi

Prof. Alessio Ciulli (University of Dundee, United Kingdom) received the Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery for his pioneering work in the field of proteolysis-targeting chimera (PROTAC) technology for drug-induced targeted protein degradation. He has made substantial contributions to the development of new ligands of von Hippel-Lindau (VHL) E3 ligase, specifically bivalent small-molecule dimerisers of the VHL E3 ubiquitin ligase (VHL-based PROTACs), and elucidated their mechanism of action. Notably, Alessio Ciulli’s research provided a rational basis for the design and optimisation of the next generation of targeted protein degradation systems.

Award Ciulli

Dr Josep Prous, Prof. Alessio Ciulli, Prof. Rui Moreira
Credits: Fabien Venturi

The life-long title of Honorary Fellows was given to

  • Dr Dave Alker for his active role within the various leading boards of the EFMC, and his extraordinary commitment to the support of the EFMC Young Medicinal Chemists’ Symposium (EFMC-YMCS). Dr Alker has been an active member of the Executive Committee, Council, and Industry Liaison committee - increasing the visibility of EFMC activities within companies which employ medicinal chemists as well as those related industries for whom medicinal chemistry is an enabling science or for whom medicinal chemists represent a significant customer base. Dr Dave Alker has significantly contributed to the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) and helped in disseminating the news and activities of the EFMC to the United Kingdom communities of Medicinal Chemists and Chemical Biologists and is regarded as a strong link between his national adhering organisation and the EFMC.
  • Prof. Gabriele Costantino has been a member of the Executive Committee of the EFMC from 2011 until 2014, before joining the Council of the EFMC from 2017 until 2019, and from 2021 until the present days. He strongly collaborated in the creation of the EFMC newsletter “MedChem(Bio)Watch” and acted as editor-in-chief for almost a decade. With its high-quality content composed of editorials, perspective articles and reports of EFMC events and activities, the newsletter greatly helped disseminating the EFMC brand to the scientific community – and contributed to strengthening the position of medicinal chemistry, chemical biology, and related fields in Europe. In addition, Prof. Costantino has significantly contributed to the Division of Medicinal Chemistry of the Italian Chemical Society and worked as powerful ambassador between the Italian community and the EFMC.
  • Dr Kristina Goncharenko for her active participation in the creation of the EFMC Young Scientists Network. She was one of the driving forces behind in this endevour in 2019 and subsequently as chair. Her vision and sense of leadership has immensely contributed to the success of the network. Dr Goncharenko also supported the EFMC within the communication team, helping to resent our Federation to the new generation via an improved presence on social media and various branding activities such as the interviews and photo competitions. In addition, Kristina Goncharenko has contributed to the Division for Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society and worked at spreading the visibility of our Federation within the Swiss community.

Dr Peter Mohr has made substantial contributions in a wide range of medicinal chemistry areas, building on an outstanding level of scientific achievement in his career, in particular in the design of chemical probes for the unravelling of biological processes as well as in the development of several first-in-class candidates. Dr Mohr has expanded the knowledge and expertise in several important disease areas such as oncology, dermatology, psoriasis, and Type II diabetes. As well as his scientific achievements, Dr Peter Mohr has contributed significantly to the Swiss Chemical Society and to the EFMC in quality of Council Member for more than 8 years as well as active members of various EFMC initiatives and working groups until today.

Alker

Honorary Fellows

Dr Luc Van Hijfte, Dr Peter Mohr, Dr Kristina Goncharenko, Prof. Gabriele Costantino, Prof. Rui Moreira
Credits: Fabien Venturi

EFMC-YSN PhD Prizes, Best Poster Prizes & Roche Studentships

Because recognising excellence and merits is important, the new generation was also celebrated during the 27th edition of the EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC). 

 

Due to the coronavirus pandemic, the EFMC-YSN PhD Prize ceremony gathered the winners and runners-up of the 3 preceding editions.

  • 2020: Dr Victor Sebastian Perez (Exscientia, United Kingdom)
  • 2021: Dr Nikolaj Sten Troelsen (Amgen Research, Denmark)
  • 2022: Dr Johannes Morstein (University of California, United States) who unfortunately could not be present & the two runners-up: Ms Vanesa Nozal Garcia (CIB - CISC, Spain) and Ms Eleonora Comeo (University of Nottingham, United Kingdom)

YSN PhD Prizes

Prof. Rui Moreira, Ms Vanesa Nozal Garcia, Dr Nikolaj Sten Troelsen, Dr Victor Sebastian Perez, Ms Eleonora Comeo

 

The EFMC Best Poster Prizes have been granted to the following participants :

  • Ben Cons (Astex)
  • Blake Curtis (Australian National University)
  • Evelyne Dietrich (Repare Therapeutics)
  • Sandra Kovachka (Côte D’azur University)
  • Caroline Lanthier (UAntwerp)
  • Angela Martin Serrano Ortiz (University of Grenoble-Alpes)
  • Pilar Suarez De Cepeda Fuentes (University of Santiago de Compostela)
  • Julian Witt (University of Hamburg)

The EFMC-ICBS Best Poster Prizes have been granted to the following participants :

  • Carlo Matera (University of Milan)
  • Doroteja Novak (University of Ljubljana)
ICBS Best Poster

Credits: Fabien Venturi

 

Finally, the 2022 EFMC-Roche Studentships, hosted by Dr Hayley Binch (F. Hoffmann-La Roche, Switzerland) rewarded excellence accomplished during a medicinal chemistry internship in industry have been granted to the following participants:

  • Mr Adam McGrath (Imperial College London)
  • Mr Sander Folker (F.Hoffmann-La Roche)
  • Ms Hannah Unsworth (University of Oxford)

EFMC-Roche Studentships

Credits: Fabien Venturi

Chemistry Europe Signs Collaboration Agreement with EFMC

Chemistry Europe journals ChemMedChem and ChemBioChem to become official journals of European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

Weinheim, Germany; Bern, Switzerland; April 5, 2022 — Chemistry Europe, an association of 16 chemical societies from 15 European countries publishing a family of high-quality scholarly chemistry journals, today announced that it has entered into a multi-year collaboration with the European Federation for Medicinal Chemistry and Chemical Biology (EFMC), an independent association representing 29 scientific organizations from 25 European countries to advance the science of medicinal chemistry and chemical biology. Under the terms of the agreement, the Chemistry Europe journals ChemMedChem and ChemBioChem will become official journals of EFMC.

The collaboration agreement aims to increase the visibility of ChemMedChem and ChemBioChem, bring valuable additional benefits to readers, authors, and early-career researchers, and thus strengthen the science of medicinal chemistry and chemical biology. ChemMedChem and ChemBioChem will become official journals of EFMC but continue to be owned by Chemistry Europe. The journals will display the label "official journal of EFMC" on their covers.

“We are looking forward to starting our collaboration with the EFMC. Our partnership is not only expected to increase the visibility of our journals ChemMedChem and ChemBioChem, but more importantly to strengthen the impact of the research of the European scientific community of medicinal chemistry and chemical biology on the wider global scenario. A number of exciting editorial projects will be developed within this agreement, also highlighting the contribution of young researchers.” says Professor Gianluca Farinola, Chemistry Europe Council Member in charge of ChemMedChem and Vice President of Società Chimica Italiana.

“We are very happy for this new step in the collaboration with Chemistry Europe, which allows for a broader dissemination and visibility of the excellent research carried out by the medicinal chemistry and chemical biology communities across Europe”, says Professor Rui Moreira, President of the EFMC.

Chemistry Europe publishes 19 high-quality scientific chemistry journals covering a very wide range of disciplines and supports scientists at every stage of their careers. EFMC promotes and strengthens the science of medicinal chemistry and chemical biology by organizing symposia and short courses, sponsoring meetings and schools, publishing on relevant topics, and presenting awards and prizes. The collaboration underscores the commitment of Chemistry Europe and EFMC to strengthen the scientific excellence of chemistry researchers from around the world.

Link https://www.chemistryviews.org/details/advertorial/11346095/Chemistry_Europe_Signs_Collaboration_Agreement_with_EFMC.html

Media Contact:
Dr. Vera Koester
Editor in Chief ChemistryViews (The Magazine of Chemistry Europe)
vkoester@wiley-vch.de
++49(0)172 3999 826

Mr Brieuc Matagne
EFMC Administrative Secretariat
administration@efmc.info

About Chemistry Europe

Founded in 1995, Chemistry Europe is an association of 16 chemical societies from 15 European countries, representing over 75,000 chemists. It publishes a family of high-quality scholarly chemistry journals, covering a very broad range of disciplines. Wiley-VCH is their publisher.

The mission of Chemistry Europe is to evaluate, publish, disseminate, and amplify the scientific excellence of chemistry researchers from around the globe in high-quality publications. It supports its members at every stage of their careers as they strive to solve the challenges that impact humankind. In all its work, Chemistry Europe values integrity, openness, diversity, cooperation, and freedom of thought. https://chemistry-europe.onlinelibrary.wiley.com/

About European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) is an independent association founded in December 1969 that represents 29 scientific organizations from 25 European countries. Its objective is to advance the science of medicinal chemistry & chemical biology by promoting cooperation and encouraging strong links between the national adhering organizations in order to deepen contacts and exchanges between medicinal chemists & chemical biologists in Europe and around the World. EFMC fulfills this objective by organizing symposia and short courses, by sponsoring meetings and medicinal chemistry schools, by publishing on relevant topics and by conferring awards and prizes. https://www.efmc.info/

About Wiley-VCH

Originally founded in 1921 as Verlag Chemie, Wiley-VCH plays an important role in providing scientists, engineers, and economists with high-quality information. Its integration within the global John Wiley & Sons Group since 1996 allows the company to distribute its program in every country on this planet. Our strength is based on our joint endeavors and success with people all over the world. From the very beginning, the publishing program covers most areas of the natural sciences, such as chemistry, physics, life sciences, medicine, engineering, and now also economics. While such information has traditionally been published in the form of journals, databases, reference works and books, online and offline services are now becoming increasingly important, alongside inter- and transdisciplinary portals. The company's staff in Weinheim, Berlin, and Zurich represent the foundation of all our services with their professional expertise and experience. https://www.wiley-vch.de/en/

EFMC statement on the invasion of Ukraine

EFMC strongly condemns Russia's invasion of Ukraine and expresses its support to the scientific community and to the Ukrainian people. Your courage and resilience are to be praised, and our thoughts are with you.

We urge the leaders at National, European, and international levels to work towards a quick and peaceful end to this situation.

EFMC supports the "Stick to Science" Initiative

EFMC is proud to support the ‘Stick to Science’ campaign, launched on 8 February, urging EU leaders, as well as the UK and Swiss governments, to place science collaboration before politics, and to quickly reach the UK’s and Switzerland’s association to Horizon Europe. Since the launch, the campaign has reached close to 4 million people on Twitter, and gathered a total of over 3400 signatures.

If you haven’t signed up to the initiative yet, please do so! These signatures are important in ensuring that we get the attention of European leaders and secure association to Horizon Europe. The initiative is open for all to sign, both as an individual or as an organisation on the dedicated website.

The site also includes a range of resources for supporters, including suggested social media posts, banners and email signature templates.

A Job/PhD or Post-Doc position to offer in medicinal chemistry or chemical biology? Use the EFMC Job Portal

The posting of Job/PhD & Post-Doc offers is free and is available for any Med Chem related jobs, in industry as well as academic positions.

Job posting is now made even simplier, you only have to provide the URL of the job application. 

Once reviewed, the position will be available on the EFMC website and in the monthly newsletter "MedChemWatch".